Optogenetics: Core Growth Enabler in the Optogenetics Market Surges As Therapeutic Approach For Parkinson's Disease And Epilepsy Cases Soar Worldwide Market, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Optogenetics Industry Market Size Be by 2025?
The expansion of the optogenetics market has been swift in the past few years. It is anticipated to inflate from $35.91 billion in 2024 to $40.9 billion in 2025, with a compound annual growth rate (CAGR) of 13.9%. The surge observed in the past can be credited to an increased prevalence of neurological disorders, a rise in funding for life sciences, advancements in drug discovery and development, the crucial role of optogenetics in mapping neural circuits and drug screening, as well as progress in neurophotonics.

What's the Long-Term Growth Forecast for the Optogenetics Market Size Through 2029?
In the coming years, the optogenetics market is anticipated to witness a swift expansion, growing to a worth of $71.21 billion in 2029. This equates to a compound annual growth rate (CAGR) of 14.9%. The predicted growth in this period is linked to a range of factors such as the use of optogenetics for therapeutic applications, clinical trials and their translation, its extension into non-neuronal cells, optogenetics application within brain-machine interfaces, and the development of new light-sensitive proteins. Further, the forecast period will also see significant trends such as advancements in optogenetic tools and technologies, partnerships with pharmaceutical firms, the application of optogenetics in drug discovery and development, its growth into non-neural cell types, and the incorporation with other imaging technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/optogenetics-global-market-report

What Are the Key Growth Drivers Fueling the Optogenetics Market Expansion?
The escalating incidences of Parkinson's disease and epilepsy worldwide are anticipated to fuel the expansion of the optogenetics market. Parkinson's disease (PD) is characterized as a brain degenerative disorder that causes motor symptoms such as slow movement, tremors, stiffness, and imbalance, supplemented by other issues like cognitive deterioration, psychological problems, sleep disorders, pain, and sensory disturbances. Epilepsy is a neurological condition that leads to seizures. In optogenetic therapy, to treat Parkinson's disease, proteins that react to specific light wavelengths are employed. These proteins can be synthesized with gene therapy methods to either turn on or off upon exposure to certain light types, leading to the restoration of normal brain function in Parkinson's disease (PD). For example, in December 2022, the Parkinson's Foundation, an American organization committed to enhancing the quality of life for those impacted by Parkinson's disease, reported a significant yearly increase in Parkinson's disease diagnoses to nearly 90,000, a significant increase from the prior estimation of 60,000. Additionally, the population of individuals living with PD in the U.S. is projected to rise from 930,000 in 2020 to 1.2 million by 2030. Consequently, the worldwide surge in Parkinson's disease and epilepsy instances is propelling the optogenetics market's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9009&type=smp

What Are the Key Trends Driving Optogenetics Market Growth?
The trend of developing innovative systems is emerging as a significant factor in the optogenetics market. Leading companies in the optogenetics market are constantly developing state-of-the-art optogenetics tools and systems to maintain their market position. An example is the launch of NeuraLight 3D Ultra by Bruker Corporation, a US-based company in optogenetics tool manufacturing, in June 2022. This advanced 3D holographic stimulation enhances optogenetics modules for advanced neuroscience and optogenetics research applications on Bruker's Ultima 2Pplus Multiphoton Microscope. NeuraLight 3D Ultra provides cutting-edge 3D holographic photostimulation, optimized for detailed functional research on neural networks and brain computation.

How Is the Optogenetics Market Segmented?
The optogenetics market covered in this report is segmented -

1) By Product: Lasers, Actuators, Sensors
2) By Application: Neuroscience, Behavioral Tracking, Retinal Disease Treatment, Other Applications
3) By End User: Hospitals And Clinics, Diagnostics Centers, Research Centers, Other End Users

Subsegments:
1) By Lasers: Continuous Wave Lasers, Pulsed Lasers, Fiber-Coupled Lasers
2) By Actuators: Channelrhodopsins, Halorhodopsins, Opto-xRs
3) By Sensors: Calcium Sensors, Voltage Sensors, Genetically Encoded Indicators

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9009&type=smp

Which Companies Are Leading the Charge in Optogenetics Market Innovation?
Major companies operating in the optogenetics market include Elliot Scientific Ltd., Shanghai Laser & Optics Century Co. Ltd., GenSight Biologics, Danaher Corporation, Coherent Inc., Thorlabs Inc., Prizmatix Ltd., Bruker Corporation, Judges Scientific Plc., Merck KGaA, The Jackson Laboratory, Noldus Information Technology BV, Applied Genetic Technologies Corporation, Circuit Therapeutics Inc., Bionic Sight LLC, Teledyne Photometrics, Campden Instruments, Nanoscope Therapeutics Inc., Laserglow Technologies, Hubner Group, Novartis, AbbVie, Physical Sciences Inc., Ray Therapeutics, OptoGenTech, opto biolabs, Neurolux, Ugenex Therapeutics, Scientifica, Cobolt Inc., Inscopix, Mightex Systems

Which Regions Are Leading the Global Optogenetics Market in Revenue?
North America was the largest region in the optogenetics market in 2024. The regions covered in the optogenetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9009

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.